12:00 AM
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

BGI, Complete Genomics deal

A U.S. subsidiary of BGI will acquire whole genome sequencing company Complete Genomics Inc. for $3.15 per share in cash, or about $117.6 million. The price is an 18% premium to Complete Genomics' close of $2.67 on Sept. 14, before...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >